Treatment of Cushing Disease With Pituitary-Targeting Seliciclib is a research paper published in The Journal of Clinical Endocrinology & Metabolism (2022). On theSindex it has a DataRank of 0. It has been cited 30 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
FDA HHS
Grant: R01 FD006106
NIDDK NIH HHS
Grant: R21 DK103198
National Institutes of Health
U.S. Food and Drug Administration
FWCI
3.81
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals